Health Center COVID-19 Survey

National Summary Report

Latest data from September 10, 2021

HRSA uses the information collected to: optimize COVID-19 testing and vaccination; track health center capacity and the impact of COVID-19 on operations, patients, and staff; and better understand training and technical assistance, funding, and other health center resource needs.

Health Center COVID-19 Survey Tool Questions

Health Center COVID-19 Survey Tool User Guide

Health Center Program Look-Alike Survey Data for COVID-19

COVID-19 Health Center Survey Interactive Data Dashboards

View cumulative vaccination data nationally; by state, territory, and freely associated state; and among patients identified as racial and/or ethnic minorities. New data views: total vaccinations (all sources) and Health Center Vaccine Program (federal allocations only).

View operational data, including testing capacity, vaccinations initiated and completed, temporary closures, staff ability to work, and visits conducted virtually.

View COVID-19 testing data by race/ethnicity.

Note: The dashboard data are updated weekly using Health Center COVID-19 Survey data.

Number of Health Center respondents = 1078 (78% of all Health Centers)

Data represent information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 518,488
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 58.28%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 66,596
Racial and/or Ethnic Minority Patients 50.29%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested by race and ethnicity, Virus Detection (PCR, antigen)2 Patients Tested Positive by race and ethnicity, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 36.84% 44.83%
White, Hispanic/Latino Patients 20.87% 18.33%
Black/African American, Non-Hispanic/Latino Patients 14.98% 14.65%
Black/African American, Hispanic/Latino Patients 0.83% 0.70%
Asian Patients3 2.13% 1.16%
American Indian/Alaska Native Patients3 1.53% 1.21%
Native Hawaiian/Other Pacific Islander Patients3 1.21% 1.45%
Patients with More than one race3 3.42% 2.60%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 6.48% 5.26%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.51% 1.98%
Unreported/Refused to Report Race and Ethnicity 9.19% 7.83%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 128,343
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 80.54%
COVID-19 Immunization Series Completed 162,839
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 81.25%
COVID-19 Immunization Series Additional 17,664
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 62.14%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 16.79% 16.42% 28.83%
White, Hispanic/Latino Patients 29.30% 30.90% 12.18%
Black/African American, Non-Hispanic/Latino Patients 14.47% 14.13% 11.38%
Black/African American, Hispanic/Latino Patients 1.53% 1.38% 1.39%
Asian Patients3 2.62% 2.79% 6.57%
American Indian/Alaska Native Patients3 1.05% 0.96% 4.46%
Native Hawaiian/Other Pacific Islander Patients3 1.48% 1.36% 0.32%
Patients with More than one race3 5.57% 5.05% 5.62%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 13.47% 14.62% 5.38%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.06% 2.02% 2.42%
Unreported/Refused to Report Race and Ethnicity 11.67% 10.36% 21.44%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 19.48%
1 to 24 Hours 27.18%
More Than 24 Hours 52.13%
N/A 1.21%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 5.94%
Staffing to administer the vaccine 27.83%
Vaccine confidence 40.72%
Vaccine storage capacity 2.23%
Vaccine supply 3.34%
Other 7.98%
None 32.75%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 89.61%
Average Percent of Health Center Visits Conducted Virtually 19.35%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 38.22%
Number of Mobile Van Sites 598
Number of Pop-up Clinics 1,143
Number of School-Based Vaccination Sites 364

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 5.57%
Refer patients to another organization that provides monoclonal antibody therapies 43.60%
None 51.30%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 13.08%
Patient awareness/education 7.88%
Staffing capacity 21.89%
Therapy administration/onsite logistics 22.63%
Other 10.39%
None 48.70%

Results from States and Territories

Select a measure on the dropdown menu to view by state or territory.

1 The reported number of patients tested does not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  September 2021